FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...

A Department of Defense–funded initiative targets underrepresented kidney cancer populations to improve clinical trial participation and address persistent disparities in access to novel therapies.

Susan Rux, RN, of Fox Chase Cancer Center, leads federally funded research to expand clinical trial access for underrepresented kidney cancer patients while mentoring the next generation of oncology ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...

Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body ...

For Scerbo, the answer traces back to a single patient, a boy she met during her pediatric rotation who was being treated for ...

Demonstrates mastery of cytokine-stimulating immunotherapy protocols, coordinating admissions, monitoring, and protocol-driven assessments with meticulous attention to detail and proactive ...

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...

Her proposal to quantify ropeginterferon alfa-2b transport during pregnancy catalyzed cross-disciplinary collaboration and ...